About us

      Founded in 2001 and headquartered in Shenzhen China, Sciarray is a global provider of in vitro diagnostics (IVD) and instruments. We focus on the providing global medical diagnostics solutions. We have owned comprehensive diagnostic technologies: molecular diagnostic/Chemiluminescence (CLIA)/Biological chip/Rapid biochemical test/Gene methylation and medical devices.

      Sciarray management team is consist of experienced and accomplished professionals, and their career experiences range from managing global research and product development projects in major international companies and institutions, hospital management, business development, marketing and sales for in vitro diagnostics. The venture backed company has devoted major efforts for developing the next generation diagnostic marker for immune disease such as Systemic Lupus Erythematosus (SLE) and look for collaboration with international partners for global markets.

      The clinic diagnostic on SLE is needed more accuracies in globe. The promoter low-methylation of Interferon-induced protein 44-like(IFI44L) gene is a new world-wide powerful marker for SLE clinic diagnostical. IFI44L promoter low-methylation is the only one high special and sensitive marker for SLE clinic diagnostics.